Cite
HARVARD Citation
Toppmeyer, D. et al. (2020). Testing considerations for phosphatidylinositol‐3‐kinase catalytic subunit alpha as an emerging biomarker in advanced breast cancer. Cancer medicine. pp. 6463-6472. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Toppmeyer, D. et al. (2020). Testing considerations for phosphatidylinositol‐3‐kinase catalytic subunit alpha as an emerging biomarker in advanced breast cancer. Cancer medicine. pp. 6463-6472. [Online].